Deal facts
- Buyer
- Fortitude Mining Holdings, Inc.
- Target
- HeartSciences Inc.
- Deal value
- Not disclosed
- Announced
- 23 June 2026
- Status
- In review
- Sector
- Healthcare
- Country
- United States
- Consideration
- shares
Sources
Fortitude Mining Holdings, Inc. and HeartSciences Inc. have agreed to merge in a transaction structured as a merger of equals. Both companies are based in the United States and operate within the healthcare sector. The deal was announced on 23 June 2026. The consideration for the merger consists entirely of shares, with no cash component reported. The specific financial value of the transaction has not been disclosed by either party. As both entities are US-based, the merger does not involve cross-border regulatory complexities typically associated with international acquisitions. The combination aims to consolidate their respective positions in the healthcare market, although specific strategic rationales are not detailed in the available data. The transaction remains in the review phase, with no completion date currently established. Stakeholders are awaiting further regulatory developments before the deal can proceed to closing. The merger represents a significant structural change for both organizations, integrating their operations under a unified corporate framework. No additional financial terms or performance conditions have been made public at this stage.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CMA invitation to comment
Fortitude Mining Holdings, Inc. M&A filing involving HeartSciences Inc.
Item 7.01. Regulation FD Disclosure. On October 6, 2026, HeartSciences Inc. (the “ Company ” or “ HeartSciences ”) issued a press release announcing that the U.S. Food and Drug Administration has granted 510(k) clearance (K260005) for the Company’s MyoVista® wavECG TM device as a 12-lead resting electrocardiograph, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K (th
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Apimeds Pharmaceuticals US, Inc. to acquire MindWave
Apimeds Pharmaceuticals US, Inc. and MindWave entered the Exit Mode archive.
- Buyer
- Apimeds Pharmaceuticals US, Inc.
- Target
- MindWave
- Deal value
- Not disclosed
- Deal type
- merger of equals
QT Imaging Holdings, Inc. to acquire QT Imaging, Inc.
QT Imaging Holdings, Inc. and QT Imaging, Inc. have agreed to merge in a transaction valued at undisclosed terms. The deal structure involves consideration through share…
- Buyer
- QT Imaging Holdings, Inc.
- Target
- QT Imaging, Inc.
- Deal value
- Not disclosed
- Deal type
- merger of equals
Cronos Group Inc. to acquire CanAdelaar B.V.
Cronos Group Inc. has agreed to acquire CanAdelaar B.V. in a strategic acquisition within the healthcare sector. The Canadian buyer will purchase the Dutch target for a…
- Buyer
- Cronos Group Inc.
- Target
- CanAdelaar B.V.
- Deal value
- EUR 57,500,000
- Deal type
- strategic acquisition
Laboratory Corporation of America Holdings to acquire BioReference Health, LLC
Laboratory Corporation of America Holdings has agreed to acquire BioReference Health, LLC in a transaction valued at 722 million US dollars. The deal, announced on 14 Oc…
- Buyer
- Laboratory Corporation of America Holdings
- Target
- BioReference Health, LLC
- Deal value
- USD 722,000,000
- Deal type
- asset sale
Silo Pharma, Inc. to acquire Larry King
Silo Pharma, Inc. has completed the acquisition of assets from Larry King. The transaction, which was announced on 14 October 2026, was finalized on 13 October 2026. Bot…
- Buyer
- Silo Pharma, Inc.
- Target
- Larry King
- Deal value
- Not disclosed
- Deal type
- asset sale
Buyer history
Fortitude Mining Holdings, Inc.
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive